January 7, 2019
“DNA researchers evaluated how well the company’s facial image analysis framework—DeepGestalt—compared to experts doing phenotypic evaluation. The company has trained its system on a global library of facial images of more than 150,000 patients through Face2Gene, an app that is free to healthcare professionals.”
The article highlights how FDNA’s advanced AI technology is pushing the boundaries of next-gen phenotyping, outperforming traditional clinician diagnoses. Using the Face2Gene platform, FDNA’s AI analyzes detailed facial features to identify phenotypic markers linked to various genetic conditions. This system leverages cutting-edge machine learning and a comprehensive database of facial images to provide highly accurate and rapid diagnostics. The article emphasizes the superior accuracy and efficiency of this next-gen phenotyping approach, enabling earlier detection and personalized treatment of genetic disorders. FDNA’s innovations are revolutionizing genetic medicine by enhancing diagnostic precision and improving patient outcomes.
